A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.
about
Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a reviewPseudomonas aeruginosa population structure revisited.Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection.Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.Diversity of virulence phenotypes among type III secretion negative Pseudomonas aeruginosa clinical isolates.New perspectives in the management of Pseudomonas aeruginosa infections.Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest IranPseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches.Central role of PAFR signalling in ExoU-induced NF-κB activation.Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.The Frequency of Exotoxin A and Exoenzymes S and U Genes Among Clinical Isolates of Pseudomonas aeruginosa in Shiraz, Iran.Internalization of Pseudomonas aeruginosa Strain PAO1 into Epithelial Cells Is Promoted by Interaction of a T6SS Effector with the Microtubule Network.Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.PcrV antibody-antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice.Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin.Environmental Reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa.Higher Prevalence of PldA, a -Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains
P2860
Q27013824-1F105201-0FC3-4BD3-BADC-527EB3E43AFDQ30913394-1BD8E892-0EA7-453F-B221-793E704507EFQ33769060-988CCDC7-6D4B-41A0-94F7-13DF8D989DBEQ33836925-7F28DC70-19D4-46C5-A8C0-5838F382F426Q34358987-8445C4EA-DEAB-43F6-827E-ED8E8BFA692CQ35783999-E4D6FD19-20DA-40C6-BB73-CB22ABCFBE33Q37510611-E1148B5C-E0B4-4949-A0AD-338F37189D58Q38243221-18DDEBFD-D509-4769-A7B7-9D29F36CDDD7Q38626784-749A6448-50A8-4345-8AD2-A42488A2D14DQ38833703-8DF2C955-AEA7-4D64-94F0-12FCBE804BDFQ39017043-7EBD49AD-A913-4CFE-86EA-3405556A2F92Q40508725-80888D90-7B9D-4A19-BF01-D5AF72195A2DQ40886060-1EBC364A-E3BF-4888-8995-ADD156D7A06EQ41189092-06C4D9DA-FB5C-4508-AD55-F945240D0459Q41672662-29CAF5B7-F1C0-4DEE-8C09-3185F3DB1BF5Q43472217-1EB9AB2A-0C34-42E3-A584-2128F312B477Q47448907-0669A972-BB99-4500-B043-66B11F2B8BB6Q52717154-78B8FC1B-5015-4C77-8E13-5201080A1801Q58694888-D9D077AA-523C-48A6-ABC3-FC2AC671E057
P2860
A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@en
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@nl
type
label
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@en
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@nl
prefLabel
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@en
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@nl
P1476
A genotypic and phenotypic com ...... rosis and bacteremia isolates.
@en
P2093
Michael A Curtis
P304
P356
10.1016/J.IJMM.2007.02.004
P577
2007-04-06T00:00:00Z